Partneringdesk Deals and Alliances In Autoimmune & Inflammatory Diseases

Innovaro Pharmalicensing
June 1, 2006
1048 Pages - SKU: PL1284781
License type:
Partneringdesk deals and alliances in autoimmune & inflammatory diseases provides an in-depth view of over 1100 deals and alliances announced in autoimmune & inflammatory diseases between 2001 and 2006, in a clear and accessible PDF format.

Reasons to purchase (USPs and key questions answered)
Partneringdesk Deals and alliances in autoimmune & inflammatory diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in:
  • the assessment of deal-making trends in the last five years
  • identifying active partners
  • tracking competitor activity
  • benchmarking deals
Partneringdesk deals and alliances in autoimmune & inflammatory diseases brings all the relevant partnering deals into one place, providing a ready reference to deal making in autoimmune & inflammatory diseases.

Report scope
The report contains:
  • fully categorized deal overviews
  • financial information where disclosed
  • company profiles of the top 25 dealmakers in the report
  • specialized indexes by company, development stage, deal type and industry sector.
  • wider coverage of Japanese deals courtesy of JCN
Forecasts, projections, market estimates
This report provides a series of charts with analyses detailing market trends in autoimmune & inflammatory diseases deal making over the period of 2001 to 2006.

Methodology
This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources.



Additional Information

Who should buy the report
This report is essential reading for board and executive management, and individuals in:
  • business development
  • licensing/partnering
  • deal making
  • business strategy
  • marketing and promotion
  • distribution and manufacturing (including contract services).
Companies analyzed/mentioned
Abbott Laboratories
AstraZeneca
Aventis
Beckman Coulter Inc
Boehringer Ingelheim GmbH
Calypte Biomedical Corp
Celltech
Corixa
Dyax Corp
Genentech Inc
Genzyme Corporation
GlaxoSmithKline
International AIDS Vaccine Initiative
Medarex
MedImmune
MedMira
Merck & Co Inc
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Novartis AG
Pfizer Inc
Roche
Schering-Plough Corporation
Serono SA
ViroLogic
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!